---
title: "Chipscreen Biosciences' brain-penetrant CS231295 tablet gets FDA IND approval, advancing global clinical dev."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250967186.md"
description: "Shenzhen-based company Chipscreen Biosciences Co., Ltd. has shared that its wholly owned subsidiary, Chipscreen Biosciences (USA) Ltd., has recently obtained Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA). This milestone was announced on July 31, 2025. The approval signifies a significant step forward for the company in advancing its pharmaceutical research and development efforts in the United States."
datetime: "2025-07-31T09:59:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250967186.md)
  - [en](https://longbridge.com/en/news/250967186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250967186.md)
---

# Chipscreen Biosciences' brain-penetrant CS231295 tablet gets FDA IND approval, advancing global clinical dev.

Shenzhen-based company Chipscreen Biosciences Co., Ltd. has shared that its wholly owned subsidiary, Chipscreen Biosciences (USA) Ltd., has recently obtained Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA). This milestone was announced on July 31, 2025. The approval signifies a significant step forward for the company in advancing its pharmaceutical research and development efforts in the United States.

### Related Stocks

- [688321.CN](https://longbridge.com/en/quote/688321.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Investeringsforeningen Nykredit Invest Balance suspender handel med udvalgte afdelinger](https://longbridge.com/en/news/286877547.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Rosenbauer Releases Interim Q1 2026 Financial Report](https://longbridge.com/en/news/286858179.md)